#12 Can Measuring DNA Damage Unlock Longevity?

intoDNA YouTube

#11 DNA Damage and Repair: The Hidden Driver Across Medicine

intoDNA YouTube

#10 An Old Idea Behind New Cancer Breakthroughs

intoDNA YouTube

#09 Cutting Waiting Times in Biomarker Testing with STRIDE®

intoDNA YouTube

#8 Biomarkers at the Heart of Precision Medicine

intoDNA YouTube

In situ detection of WRN activity and R-Loop accumulation at DNA double-strand breaks using the dSTRIDE™ platform

O. Wójcikowska, E. Szafraniec, M. Bartyńska, M. Białecka, Z. Prucsi, M. Kordon-Kiszala, K. Solarczyk

Androgen receptor inhibition extends PARP inhibitor activity in prostate cancer models beyond BRCA mutations and defects in homologous recombination repair

Giuditta Illuzzi, Alessandro Galbiati, Anna D. Staniszewska, Robert Hanson, Chrysiis Michaloglou, Sophie L. Cooke, Karolina Uznanska, Maja Białecka, Kamil Solarczyk, Harveer S. Dev, Charlie E. Massie, Mark R. Albertella, Elisabetta Leo, Josep V. Forment, Mark J. O’Connor

#7 How STRIDE® Detects Cancer’s DNA Repair Weakness

intoDNA YouTube

#6 Visualizing DNA Repair: The STRIDE® Technology Explained

intoDNA YouTube

#5 Beyond Genomic Scars: The Future of Biomarkers for Cancer Therapy

intoDNA YouTube

#4 Predicting Treatment Success: A Biomarker Strategy for DDR Inhibitors

intoDNA YouTube

#3 Seeing DNA Breaks with X-Ray Precision: How STRIDE® Transforms DNA Damage Detection

intoDNA YouTube

#2 DNA Damage Biomarkers: Measuring the Impact of DDR Inhibitors with STRIDE®

intoDNA YouTube

#1 Turning DNA Repair into a Therapeutic Strategy: Precision Oncology with STRIDE®

intoDNA YouTube

Replication stress detection using STRIDE® technology platform

K. Stepien, K. Schirmeisen, D. Jaśniak, Z. Prucsi, J. Lechowski, M. Bartyńska, M. Kordon-Kiszala, K. Solarczyk

STRIDE™: a platform for quantitative DNA damage response dissection

M. Białecka, O. Wójcikowska, K. Białas, D. Jaśniak, J. Lechowski, M. Bartyńska, K. Stepien, F. Sierpowski, K. Schirmeisen, Z. Prucsi, A. Waligórska, M. Kordon-Kiszala, K. Solarczyk

STRIDE™: Overcoming the limitations of γH2AX as a DNA damage detection method

K. Białas, O. Wójcikowska, D. Jaśniak, M. Bartyńska, J. Lechowski, S. Ostrowska-Paton, Z. Prucsi, I. Aylott, M. Białecka, A. Waligórska, M. Kordon-Kiszala, K. Solarczyk

Hyper-recombination in ribosomal DNA is driven by long-range resection-independent RAD51 accumulation

Gál, Z., Boukoura, S., Oxe, K.C. et al.

STRIDE® DNA Damage Response Assays by Kamil Solarczyk — the CTO and a co-Founder of intoDNA.

intoDNA YouTube

STRIDE® in DNA Damage Analysis by Magda Kordon — the CEO and a co-Founder of intoDNA.

intoDNA YouTube

STRIDE™ as a technology platform for accurate measurement of DNA breaks and breaks-associated repair proteins (AACR Synthetic Lethality Special Conference 2024)

A. Uherek, K. Stępień, O. Wójcikowska, K. Solarczyk, et al.

LP-184, a Novel Acylfulvene Molecule, Exhibits Anticancer Activity against Diverse Solid Tumors with Homologous Recombination Deficiency

A. Kulkarni, J. Zhou, Z. Prucsi, K. Solarczyk, et al.

Novel dSTRIDE™-HR assays can accurately assess DNA repair defects in human cancers and distinguish HR status of tumors (AACR 2024)

M. Jarosz, Z. Prucsi, F. Sierpowski, K. Solarczyk, et al.

Measuring the activity of SMUG1 DNA glycosylase with a novel sSTRIDE™-SMUG1 assay (AACR 2024)

K. Stępień, F. Sierpowski, Z. Prucsi, K. Solarczyk, et al.

Studying the MoA of the next generation chemotherapeutic LP-284, a small molecule acylfulvene in a chronic myelogenous leukemia cell line model using STRIDE™

Studying the effects of alpha and beta-emitters alone and in combination with a DDR inhibitor in a human cell line model

Studying the MoA of a DDR inhibitor in Patient-Derived Xenograft (PDX) models using STRIDE®

DNA damage levels in development of DDR inhibitors — why gammaH2AX is not enough?

intoDNA YouTube

Detection of DNA damage using STRIDE® as a new PD biomarker in liquid biopsies and FFPE tissue sections

K. Solarczyk, A. Waligórska, M. Szczygieł, P. Waring, G. Jones, et al.

Development and validation of a customized, functional STRIDE®-based assay to measure Mismatch Repair (MMR) pathway activity in cells

sSTRIDE™ as a technology platform for the detection and measurement of DNA breaks in various DNA repair pathways (DDR Inhibitors Summit 2024)

M. Białecka, K. Uznańska, O. Wójcikowska, K. Solarczyk, et al.

LP-284, a small molecule acylfulvene, exerts potent antitumor activity in preclinical non-Hodgkin’s lymphoma models and in cells deficient in DNA damage repair

J. Zhou, D. Sturtevant, C. Love, A. Kulkarni, K. Bhatia, et al.

Development and validation of a novel sSTRIDE™-MMR functional assay to study the efficiency of MMR inhibitors (AACR 2023)

M. Białecka, K. Solarczyk, K. Uznańska, O. Wójcikowska, et al.

Novel functional dSTRIDE™-HR assays to report on the status of homologous recombination repair in cancer cells (AACR 2023)

K. Solarczyk, A. Waligórska, K. Uznańska, Z. Prucsi, et al.

Let’s not take DNA breaks for granted. The importance of direct detection of DNA breaks for the successful development of DDR inhibitors

M. Kordon-Kiszala and K. Solarczyk

Ubiquitinated PCNA drives USP1 synthetic lethality in cancer

A. Simoneau, J. Engel, M. Bandi, K. Lazarides, S. Liu, et al.

Breakage of CRISPR/Cas9-Induced Chromosome Bridges in Mitotic Cells

M. Rodriguez-Muñoz, M. Serrat, D. Soler, A. Genescà and T. Anglada

PARP7 negatively regulates the type I interferon response in cancer cells and its inhibition triggers antitumor immunity

J. Gozgit, M. Vasbinder, R. Abo, K. Kunii, K. Kuplast-Barr, et al.

intoDNA — meet STRIDE®

intoDNA YouTube

STRIDE—a fluorescence method for direct, specific in situ detection of individual single- or double-strand DNA breaks in fixed cells

M. Kordon-Kiszala, M. Zarębski, K. Solarczyk, H. Ma, T. Pederson, J. Dobrucki